Recent Advances in Medical Applications of Synchrotron Radiation
Stanford Synchrotron Radiation Laboratory
March 4-5, 2002
Program Director: Edward Rubenstein
Keith Hodgson
James Rubenstein
Katsuhito Yamasaki
Helene Elleaume
Giuliana Tromba
Wolf-Rainer Dix
Kazuki Hyodo
Barton Lane
William Thomlinson
Hiroshi Sugiyama
< font face="Verdana, Arial, Helvetica, sans-serif" size="2">Joseph Roberson
Masami Ando
John Kinney
Avraham Dilmanian
Dean Chapman
Zhong Zhong< /font>
Brenda Laster
Roman Tatchyn
Pau l Csonka
New Results of the Large Human Study on Intravenous Coronary Angiography with Synchrotron Radiation

W.-R.Dix(a), W.Kupper(b), M.Lohmann(c), J.Metge(a), B.Reime(a), E.Rubenstein(d)

(a)HASYLAB at DESY, Hamburg, Germany
(b)Heart Center, Bad Bevensen, Germany
(c)University of Siegen, Dept. of Physics, Germany
(d)Stanford University School of Medicine, Stanford CA, USA
The method of dichromography with synchrotron radiation was first developed at SSRL. It was applied for intravenous coronary angiography, and the first human subjects were examined in 1986. Meanwhile the investigation of patients using this technique are performed at several synchrotron radiation laboratories. The method allows the visualization of very low contrast of iodine down to a mass density of 1 mg/cm², corresponding to a dilution of the contrast agent by a factor of 40 in small coronary arteries of 1 mm in diameter.

At the Hamburger Synchrotronstrahlungslabor HASYLAB at DESY in Hamburg, the NIKOS-system was developed for the new method. To date a total of 379 patients were investigated with the system with 230 of the 379 patients in cluded in a study with a fixed protocol. The goal of the study was validation of the intravenous method versus conventional selective coronary angiography with the hypothesis that satisfactory diagnostic quality for follow-up patients can be reached with the new intravenous method compared to the conventional selective one. As a result, the independent reviewers reached a positive predictive value of 83% for all segments of all target vessels including side branches down to 0.8mm in diameter, stents and bypasses, and a negative predictive value of 96%.

Furthermore, the intravenous coronary angiography is compared with the competing methods such as MRI, EBCT and MSCT. The advantages and disadvantages of the different methods are determined. One major advantage of MRI is the possibility of determining not only the morphology , but also function parameters such as perfusion, vitality and cardiac function. It is therefore possible that this same information might be determined from the study of intravenous angiograms. Very preliminary results are promising.

Overall the work shows that the method will not replace selective coronary angiography but it could be used for several applications without risk and with go od results to the patients. One obvious application is the control of stents. Another interesting application could be early and late post-operative control of bypasses.

return to agenda